<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
    <PublisherImprintName>Humana Press</PublisherImprintName>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
      <SeriesSubTitle Language="En">Methods and Protocols</SeriesSubTitle>
      <SeriesAbbreviatedTitle>Methods Molecular Biology</SeriesAbbreviatedTitle>
    </SeriesInfo>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
        <BookID>978-1-60327-931-4</BookID>
        <BookTitle>Neural Cell Transplantation</BookTitle>
        <BookSubTitle>Methods and Protocols</BookSubTitle>
        <BookVolumeNumber>549</BookVolumeNumber>
        <BookSequenceNumber>549</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-931-4</BookDOI>
        <BookTitleID>160368</BookTitleID>
        <BookPrintISBN>978-1-60327-930-7</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-931-4</BookElectronicISBN>
        <BookEdition>1</BookEdition>
        <BookChapterCount>16</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="L" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="L16008" Priority="1" Type="Secondary">Cell Biology</BookSubject>
          <BookSubject Code="L16010" Priority="2" Type="Secondary">Stem Cells</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>David</GivenName>
              <FamilyName>Gordon</FamilyName>
            </EditorName>
            <Contact>
              <Email>d.gordon@bristol.ac.uk</Email>
            </Contact>
          </Editor>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>Neil J.</GivenName>
              <FamilyName>Scolding</FamilyName>
            </EditorName>
            <Contact>
              <Phone>+440177918-6632</Phone>
              <Email>n.j.scolding@tesco.net</Email>
            </Contact>
          </Editor>
          <Affiliation ID="AffID1">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="AffID2">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Part ID="Part2">
        <PartInfo OutputMedium="All" TocLevels="0">
          <PartID>2</PartID>
          <PartSequenceNumber>2</PartSequenceNumber>
          <PartTitle> Practical/Methodological Chapters</PartTitle>
          <PartChapterCount>13</PartChapterCount>
          <PartContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-931-4</BookID>
            <BookTitle>Neural Cell Transplantation</BookTitle>
          </PartContext>
        </PartInfo>
        <Chapter ID="Chap12" Language="En">
          <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
            <ChapterID>12</ChapterID>
            <ChapterNumber>12</ChapterNumber>
            <ChapterDOI>10.1007/978-1-60327-931-4_12</ChapterDOI>
            <ChapterSequenceNumber>12</ChapterSequenceNumber>
            <ChapterTitle Language="En">Transplantation of Oligodendrocyte Progenitor Cells in Animal Models of Leukodystrophies</ChapterTitle>
            <ChapterFirstPage>175</ChapterFirstPage>
            <ChapterLastPage>185</ChapterLastPage>
            <ChapterCopyright>
              <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
              <CopyrightYear>2009</CopyrightYear>
            </ChapterCopyright>
            <ChapterHistory>
              <RegistrationDate>
                <Year>2009</Year>
                <Month>1</Month>
                <Day>5</Day>
              </RegistrationDate>
              <OnlineDate>
                <Year>2009</Year>
                <Month>3</Month>
                <Day>23</Day>
              </OnlineDate>
            </ChapterHistory>
            <ChapterGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ChapterGrants><ChapterContext>
              <SeriesID>7651</SeriesID>
              <PartID>2</PartID>
              <BookID>978-1-60327-931-4</BookID>
              <BookTitle>Neural Cell Transplantation</BookTitle>
            </ChapterContext>
          </ChapterInfo>
          <ChapterHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1_12" CorrespondingAffiliationID="Aff1_12">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Yoichi</GivenName>
                  <FamilyName>Kondo</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_12">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ian</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Duncan</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>kondoy@svm.vetmed.wisc.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1_12">
                <OrgDivision>Department of Medical Sciences, School of Veterinary Medicine</OrgDivision>
                <OrgName>University of Wisconsin-Madison</OrgName>
                <OrgAddress>
                  <Street>2015 Linden Drive</Street>
                  <Postcode>53706</Postcode>
                  <City>Madison</City>
                  <State>WI</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1_12" Language="En" OutputMedium="All">
              <Heading>Summary</Heading>
              <Para>Leukodystrophies represent a wide variety of hereditary disorders of the white matter in the central nervous system, where the patients, mostly in infancy or childhood, suffer from progressive and often fatal neurological symptoms due to either a delay or lack of myelin development or loss of myelin. As only supportive therapies are available for the majority of the leukodystrophies, replacing genetically defective oligodendrocytes with intact oligodendrocytes by transplantation has a potential as a curative therapy. Animal models of leukodystrophies have been valuable in developing effective strategies of myelin repair in human diseases. This chapter discusses the animal models of leukodystrophies and describes methods for (a) derivation of mouse oligodendrocyte progenitor cells (OPCs) in vitro as a source of donor myelin-forming cells and (b) transplantation of OPCs into the brain and spinal cord of mouse models of leukodystrophies.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Key words:</Heading>
              <Keyword>Leukodystrophy</Keyword>
              <Keyword>Myelin repair</Keyword>
              <Keyword>Oligodendrocyte progenitor</Keyword>
              <Keyword>Oligosphere</Keyword>
              <Keyword>Transplantation</Keyword>
            </KeywordGroup>
          </ChapterHeader>
          <Body>
            <Section1 ID="Sec1_12">
              <Heading>Introduction</Heading>
              <Para>The leukodystrophies are composed of a rare, but devastating, group of diseases of the white matter of the central nervous system (CNS). They encompass both diseases where myelination of the CNS delayed and absent, to those where myelination begins normally but subsequently demyelination ensues, resulting in delays in normal development of the affected children or the loss of neurologic function in previously normal children. Pelizaeus–Merzbacher disease (PMD) is the archetypical myelin development disorder, that along with its milder form, spastic paraplegia type II (SPG II), results in a range of severity of myelin abnormality from severe dysmyelination to myelin defects. The molecular defect in these patients is a mutation or duplication of the myelin protein <Emphasis Type="Italic">plp 1</Emphasis> gene (<CitationRef CitationID="CR1_12">1</CitationRef>–<CitationRef CitationID="CR5_12">5</CitationRef>). In severely affected patients, practically no myelin is present throughout the CNS. In contrast to this developmental disorder, the X-linked recessive disease, adrenoleukodystrophy (ALD), and the autosomal recessive disorders, Krabbe’s disease (globoid cell leukodystrophy) and metachromatic leukodystrophy (MLD), are characterized by massive demyelination. In the latter two disorders, demyelination also affects the peripheral nervous system (PNS). ALD can present in several forms, but in the most common acute cerebral form, the onset of disease and underlying demyelination begins around 5–6 years of age with a fulminant course of 2–3 years. In contrast, both Krabbe’s disease and MLD usually develop in the first year of life with death in 2–3 years. In Krabbe’s disease, there is a wide range of mutations in the galactocerebrosidase gene (<CitationRef CitationID="CR6_12">6</CitationRef>) and in MLD, mutations occur in the arylsulfatase A gene.</Para>
              <Para>A common feature of all of these diseases is that no treatments are available that result in myelination or myelin restoration. Therapies such as dietary supplementations (e.g., Lorenzo’s Oil in ALD) and bone marrow (<CitationRef CitationID="CR7_12">7</CitationRef>) or cord blood transplantation (<CitationRef CitationID="CR8_12">8</CitationRef>) have been useful in ameliorating or delaying the disease onset and severity, but these do not promote remyelination of the nervous system.</Para>
              <Para>In efforts to repair the myelin defects in these diseases, certain animal models have and are proving invaluable. These models, collectively known as the myelin mutants, are a group of spontaneous mutations occurring in a range of species where the defect occurs in the gene(s) mutated or implicated in the leukodystrophies. In particular, there is a large group of X-linked mutants with mutations in the <Emphasis Type="Italic">plp 1</Emphasis> gene. Usefully, there is also a group of animals with mutations in the galactocerebrosidase gene that are excellent models of Krabbe’s disease. In addition to these spontaneous mutants, transgenic or knockout mice or rats, in which the leukodystrophy genes have been targeted, are also useful in exploring repair of the CNS. These include mice with knockouts of the ALD gene(s) (<CitationRef CitationID="CR9_12">9</CitationRef>–<CitationRef CitationID="CR11_12">11</CitationRef>) or arylsulphatase A (MLD) (<CitationRef CitationID="CR12_12">12</CitationRef>). These latter models demonstrate the biochemical effects of these diseases but not the severe phenotypic abnormalities. Nonetheless, they have been informative in gene therapy experiments in which there has been some evidence of myelin repair (<CitationRef CitationID="CR13_12">13</CitationRef>).</Para>
              <Para>In the mutants noted above, myelin repair has been attempted experimentally by the transplantation of myelin-producing cells. Greatest attention has been paid to the models of PMD, particularly the myelin deficient (<Emphasis Type="Italic">md</Emphasis>) rat (<CitationRef CitationID="CR14_12">14</CitationRef>–<CitationRef CitationID="CR17_12">17</CitationRef>), and the canine mutant, the <Emphasis Type="Italic">shaking</Emphasis> pup (<CitationRef CitationID="CR18_12">18</CitationRef>). These studies have shown that cell transplantation can result in large areas of myelination at the transplantation site, and that this can be scaled up from rodent species to larger animal models such as the <Emphasis Type="Italic">shaking</Emphasis> pup (<CitationRef CitationID="CR19_12">19</CitationRef>). The lack of the proteolipid protein in the <Emphasis Type="Italic">md</Emphasis> rat makes the evaluation of success of the transplant straightforward. Likewise, lack of myelin basic protein (MBP) in the <Emphasis Type="Italic">shiverer</Emphasis> (<Emphasis Type="Italic">shi</Emphasis>) mouse has led it to be the most used model to test the myelinating capacity of many cell types and both allo- and xenografts (<CitationRef CitationID="CR20_12">20</CitationRef>–<CitationRef CitationID="CR23_12">23</CitationRef>). While not a model of known leukodystrophy, the lack of myelin in <Emphasis Type="Italic">shi,</Emphasis> and the fact that it lives up to 4 months, makes it very useful. In contrast, the other murine leukodystrophy models have been less utilized to study myelin repair by cell transplantation.</Para>
              <Para>The cells that have been transplanted into the mutants range from those of the oligodendrocyte lineage to Schwann cells. While the Schwann cells are of great interest, those of the oligodendrocyte lineage are likely to offer the greatest hope for large scale repair. A consensus of the experimental results to-date using such cells suggests that cells from the earlier stages of the lineage, either stem cells or progenitors, will be the most useful source of myelinating oligodendrocytes. In this chapter we will discuss these cells and the methods to produce them in large numbers for myelin repair.</Para>
            </Section1>
            <Section1 ID="Sec2_12">
              <Heading>Materials</Heading>
              <Section2 ID="Sec3_12">
                <Heading>OPC Culture from Mouse Neonates</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Mouse neonates (postnatal days 0–3).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Dissecting stereomicroscope (e.g., Nikon SMZ series).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Four pairs of fine forceps (e.g., #5, Fine Scientific Tools, sterile).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Cultureware (T-25 flasks, 60-mm plastic dishes, 70-μm cell strainer, 50-mL conical tubes).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>OPC Isolation Buffer: Hanks’ balanced salt solution (HBSS; without Ca<Superscript>2+</Superscript>, Mg<Superscript>2+</Superscript>) containing 2 mM EDTA, 10 mM HEPES, and 1× penicillin/streptomycin.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Trypsin/EDTA: 0.25% trypsin/1 mM EDTA (Invitrogen).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>DNase I (Worthington): Reconstitute at 2 mg/mL in HBSS. Filter-sterilize and store aliquots at −20°C.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Dulbecco’s Modified Eagle’s Medium (DMEM, Invitrogen).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Fetal Bovine Serum (FBS, HyClone).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Mouse oligosphere medium: Neurobasal-A medium containing 1× B27 supplement (Invitrogen), 2 mM glutamine, 2 μg/mL heparin, and 1× penicillin/streptomycin.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>11.</ItemNumber>
                      <ItemContent>
                        <Para>Murine recombinant basic-FGF and PDGF-AA (PeproTech). Adjust to 10 μg/mL in HBSS containing 2% bovine serum albumin (BSA) and store the aliquots at −20°C. Use up the thawed vial in 2 weeks.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec4_12">
                <Heading>Dissociation of Oligospheres</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Fire-polished Pasteur pipette: Plug the end of 9-in. glass pipettes (Fisher Scientific) with cotton and autoclave. Create a small and smooth bore (430–450 μm diameter) by flaming the pipette tip with Bunsen burner. Pretreat the inner wall of pipette with HBSS/2% BSA – this prevents loss of spheres on the pipette wall. Alternatively, the pipettes can be coated with Sigmacote (Sigma) before autoclaving.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec5_12">
                <Heading>Transplantation</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Recipient mice (e.g., twitcher mice, stock# 000845 and shiverer mice, stock# 001428, Jackson Laboratory).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Needle/pipette puller (David Kopf Instrument).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Surgical stereomicroscope (e.g., Nikon SMZ series).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Isoflurane anesthesia system (vaporizer, O<Subscript>2</Subscript> cylinder, etc.).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Hamilton syringe (10 μL, #80075).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Programmable syringe pump (GENIE, Kent Scientific).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Borosilicate glass capillary (1B100F-4, World Precision Instruments). Heat-pull the capillary and connect with the Hamilton syringe via PTFE tubing. Fill inside of the injection system with sterile saline and draw and eject a few microliters of HBSS/2% BSA to pretreat the inner wall of the needle.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>31-gauge insulin syringe (Becton Dickinson, Ultra-Fine II). Bend the needle tip with a needle holder, so the needle has approximately a 120° angle.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Heating pad (heating lamp is not recommended).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Microdrill and a 0.5-mm diameter steel burr (Fine Scientific Tools).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec6_12">
              <Heading>Methods</Heading>
              <Section2 ID="Sec7_12">
                <Heading>OPC Culture from Mouse Neonates</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Spray 70% ethanol on the pups and decapitate them with sharp scissors. Under a dissection microscope in a laminar flow hood, remove the brain with two pairs of fine forceps and transfer it to 5 mL of ice-cold Isolation Buffer in a 60-mm culture dish. Using new fine forceps, remove the meninges and choroid plexus. In a new dish with 4.5 mL of Isolation Buffer, mince the brain into &lt;1 mm<Superscript>3</Superscript> blocks and transfer the tissue with the buffer into a 50-mL conical tube.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Add 0.5 mL of trypsin/EDTA and 50 μL of DNase I to the tube and incubate at 37°C for 20 min. Inactivate trypsin by adding 5 mL of DMEM/10% FBS and dissociate the tissue by pipetting with a 10-mL pipette up and down 10–15 times without making bubbles. Filtrate the cell suspension through a 70-μm cell strainer. Wash off the strainer by adding 10 mL of Isolation Buffer. Centrifuge at 200 × <Emphasis Type="Italic">g</Emphasis>, 7 min. Discard supernatant.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Resuspend the cells in 4 mL of mouse oligosphere medium and transfer the cells to a T-25 flask. Add basic-FGF and PDGF-AA at 20 ng/mL and 10 ng/mL, respectively. Culture the cells in a humidified incubator at 37°C, 5% CO<Subscript>2</Subscript>. Exchange half of medium every 2–3 days. A number of spheres will form in 7 days. Cultures for transplantation are best used between 1 and 2 months (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig1">1</InternalRef>; <Emphasis Type="Bold">Notes</Emphasis>
                          <InternalRef RefID="Sec13_12">2</InternalRef> and <InternalRef RefID="Sec13_12">3</InternalRef>.)<Figure Category="Standard" Float="Yes" ID="Fig1">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 1.</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>Culture of oligodendrocyte progenitor cells (OPCs) as oligospheres. A floating oligosphere derived from the neonatal CNP-EGFP transgenic mouse (<CitationRef CitationID="CR24_12">24</CitationRef>) is illustrated, from which cells have migrated out and adhered to the plastic dish, with bi- or multipolar processes, the typical morphology of OPCs</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-931-4_12_Fig1_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                            </MediaObject>
                          </Figure>
                        </Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec8_12">
                <Heading>Dissociation of Oligospheres</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Collect oligospheres in a 15-mL conical tube. Spin down the spheres at 200 × <Emphasis Type="Italic">g</Emphasis>, 3 min. Discard supernatant and wash the pellet with Isolation Buffer at 200 × <Emphasis Type="Italic">g</Emphasis>, 3 min. Discard the supernatant and add 2 mL of trypsin/EDTA. Incubate the tube in the water bath for 5 min at 37°C.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Triturate the spheres by pipetting up and down several times with a fire-polished Pasteur pipette connected to a Pipet-Aid dispenser (Drummond). Sit the cell suspension until unbroken spheres settle on the bottom (approximately 1 min). Transfer the supernatant to a new 15-mL tube containing 1 mL of DMEM/10% FBS. Add 2 mL of fresh trypsin/EDTA to the unbroken spheres.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Repeat <Emphasis Type="Bold">step 2</Emphasis> once or twice until the majority of spheres are dissociated into single cells. Count the number of cells in the single cell suspension and check their viability by Trypan blue staining.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Centrifuge the cell suspension at 200 × <Emphasis Type="Italic">g</Emphasis> for 7 min at 4°C. Discard the supernatant and adjust the cell concentration to 50,000–100,000 cells/μL with HBSS. Keep the cells in a 0.5-mL microcentrifuge tube on ice until and during transplantation surgery (<Emphasis Type="Italic">also see</Emphasis>
                          <Emphasis Type="Bold">Notes</Emphasis>
                          <InternalRef RefID="Sec13_12">4</InternalRef>–<InternalRef RefID="Sec13_12">6</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec9_12">
                <Heading>Transplantation into the Neonatal Brain</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Wrap a mouse neonate in 4 in × 4 in. gauze and cover in crushed ice. The pup will be cryoanesthetized approximately in 2 min, showing pale skin, no movement, and no respiration. The time may need to be optimized for each laboratory.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Fill the heat-pulled needle with 2 μL of cell suspension by drawing a plunger. Hold the needle with your fingers and insert it into the brain at the level of bregma, 1 mm lateral from the midline, and 1.5 mm deep from the surface of skin. Marking the needle with a fine permanent pen at 1.5 mm from the tip will help control the depth of insertion. Inject the cells in 1 min using the programmable pump. Perform injection under the surgical microscope, so that the position of hand-held needle is properly fixed. Wait for 30 s before withdrawing the needle to prevent reflux of the injected cells. Uni- or bilateral injection can be performed. Warm up the pup on a heating pad. Return the pup to the mother after it starts breathing and moving.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec10_12">
                <Heading>Transplantation into the Brain of Young/Adult Mice</Heading>
                <Para>Intraparenchymal injection into the brain can be performed in young/adult mice (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig2">2</InternalRef>). Isoflurane gas (1.0–1.7% with 0.5 L/min O<Subscript>2</Subscript>) is used for anesthesia. For adult mice, stereotactic frames are commercially available, which may yet be too large for small mice of 20–30 days old. For these mice, we use a hand-made Styrofoam mold to fix the head and hold the surface of skull perpendicular to the needle insertion. After a midline skin incision, the skull is exposed and a burr hole is made carefully using a microdrill with a 0.5-mm burr so as not to damage the dura matter. The coordinates to deliver the cells to the subcortical white matter will vary depending on the size of animals. For 21-day-old twitcher mice, we have been successful with the coordination of 0 mm anterior–posterior to the bregma, 2 mm lateral to the midline, and 2 mm ventral from the dura matter. After injection through the heat-pulled glass needle (hand-held or fixed on the stereotactic frame), the bur hole is filled with bone wax and skin incision closed.<Figure Category="Standard" Float="Yes" ID="Fig2">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 2</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Engrafted oligodendrocytes/myelin in the subcortical white matter of twitcher mouse brain. A twitcher mouse received intraparenchymal transplantation of OPCs derived from the CNP-EGFP transgenic mouse at P21 and was sacrificed 4 weeks after surgery. OPCs injected into the corpus callosum (<Emphasis Type="Italic">arrow</Emphasis>) spread along the white matter tract and differentiated into myelinating oligodendrocytes, expressing EGFP marker protein under the control of 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNP) promoter. Oligodendrocyte cell bodies show intense EGFP signals and the cell processes/myelin to a less extent. (b) is a higher magnification of the graft shown in (a). <Emphasis Type="Italic">Cx</Emphasis> Cerebral cortex and <Emphasis Type="Italic">V</Emphasis> Lateral ventricle</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject>
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-931-4_12_Fig2_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                    </MediaObject>
                  </Figure>
                </Para>
              </Section2>
              <Section2 ID="Sec11_12">
                <Heading>Transplantation
into the Dorsal White Matter of the Spinal Cord</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Anesthetize a 3–4-week-old mouse with isoflurane gas and place it onto a frame. Because the target area is small and shallow from the cord surface, it is important to keep the cord from respiratory movement during injection by stabilizing the spinal column using a commercially available small-animal frame or one that is handmade. A pair of hooked forceps connected to a stable frame can maintain the stability of the spinal column of small mice.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Under the surgical microscope, make a dorsal midline skin incision and remove the spinous process at the thoracolumbar level. For a small pup, you can do so by cutting the lamina of vertebral arch with iris scissors (dedicated to this purpose);
while for a young/adult mouse, a microdrill with a 0.5-mm burr may be useful to cut the lamina.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Expose the dorsal column and clear the surface with a cotton applicator or a surgical spade. Do not damage the median dorsal spinal artery, or bleeding will require clearing of the surgical field. Alternatively, you may electrocauterize the artery, which will allow you to inject right on the midline. With a bent 31-gauge needle, cut a short length of the dura matter at the injection site.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Using a micromanipulator, insert the pulled glass needle in which 1 μL of cell suspension (50,000–100,000 cells) is loaded, to the depth of 0.5 mm. Inject 1 μL at 0.2 μL/min and withdraw the needle 1 min after the injection is finished.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Close the skin incision and place the animal on the heating pad until recovery (<Emphasis Type="Italic">also see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec13_12">7</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec12_12">
                <Heading>Histological Evaluation</Heading>
                <Para>A critical issue will be to distinguish the donor-derived myelin/oligodendrocyte from the endogenous cells and their myelin sheaths. The simplest method is to use donor OPCs derived from a transgenic mouse that expresses a marker protein such as enhanced green fluorescent protein (EGFP) or β-galactosidase. Choosing a promoter gene specific to oligodendrocyte lineage cells helps identify the donor myelin/oligodendrocyte without further histological processing (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig2">2</InternalRef>).</Para>
                <Para>Choosing a myelin mutant as the recipient provides an advantage in identifying the donor-derived myelin. For example, the shiverer mouse lacks compact myelin sheaths in the CNS due to a deletion in the MBP gene. Therefore, immunolabeling for MBP exclusively identifies the donor-derived myelin.</Para>
                <Para>One-micrometer semi-thin sections for toluidine blue myelin staining and ultrathin sections for electron microscopy can be obtained from the tissue embedded in epon plastic. These methods are valuable in detailed observation of donor-derived myelination as well as pathological changes in axon/myelin (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig3">3</InternalRef>).<Figure Category="Standard" Float="Yes" ID="Fig3">
                    <Caption Language="En">
                      <CaptionNumber>Fig.3.</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Toluidine blue myelin staining on a 1-μm section of plastic embedded rat spinal cord. Shown is the spinal cord of the myelin deficient rat transplanted with OPCs derived from a normal rat brain. (a) The engrafted ventral white matter was extensively myelinated, yielding darker blue staining compared to the unmyelinated areas (<Emphasis Type="Italic">asterisk</Emphasis>). (b) Numerous myelinated axons are observed at a higher magnification. (c) Axons with various diameters are wrapped by different thickness of myelin. In general, donor-derived myelin is thinner than normally developed endogenous myelin. Here, however, myelin of large axons appears to be as thick as normal myelin. One nucleus (N) is possibly an oligodendrocyte.</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject>
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-931-4_12_Fig3_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                    </MediaObject>
                  </Figure>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec13_12">
              <Heading>Notes</Heading>
              <Para>
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para>Although not mentioned throughout the text, animal care procedures (e.g., sterile techniques and pain control) must properly follow federal or national guidelines and of your institution.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para>OPCs can be derived from the rat using a medium containing 30% supernatant from the culture of B104 neuroblastoma cell line (<CitationRef CitationID="CR25_12">25</CitationRef>). Oligospheres can form directly from the striatal tissue or can be induced from neurosphere (neural stem cell) cultures (<CitationRef CitationID="CR26_12">26</CitationRef>).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para>Beyond 2 months of culture, growth of murine and canine (<CitationRef CitationID="CR27_12">27</CitationRef>) oligosphere cells slows down. The cells that migrate out from the sphere and adhere on the flask bottom often show abnormal morphologic changes such as fibroblast-like elongated processes, which may be attributed to the effect of FGF-2. These cells are not good source of myelin-forming cells for transplantation. In contrast, rat oligosphere cells may be used for a more extended time.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para>Alternatively, oligospheres can be triturated in one step by using a fire-polished Pasteur pipette with a smaller bore size (&lt;0.4 mm). This method works well for rat oligospheres. However, a large number of dead cells may be found in murine and canine spheres, because their OPCs appear to be more fragile to the shear stress.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para>Dissociated oligosphere cells can be plated to evaluate their in vitro differentiation. Cells are plated at 50,000 cells per 12-mm round glass coverslips coated with 0.1 mg/mL poly-<Emphasis Type="SmallCaps">l</Emphasis>-ornithine and cultured with DMEM/FBS in a 24-well plate. When the medium contains 0.5–1% FBS, the cells differentiate into mature oligodendrocytes in 1 week, whereas the majority of cells become astrocytes with 10% FBS. In rats, more than 95% oligodendroglial differentiation can be achieved. However, the same method leads to as much as 20% oligodendroglial differentiation in murine and canine oligospheres, indicating that there are species differences in oligodendrocyte development.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para>In mice, it is our experience that oligosphere-derived OPCs do not show widespread migration into the brain parenchyma when transplanted into the third ventricle. Therefore, we prefer transplanting directly into the brain parenchyma (<CitationRef CitationID="CR23_12">23</CitationRef>). As previously reported, rat OPCs in the ventricle can migrate extensively in the CNS parenchyma (<CitationRef CitationID="CR28_12">28</CitationRef>).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para>The size of needle for transplantation is critical, especially in the spinal cord. A large needle wound induces inflammation, which may then reduce the survival of graft and/or damage host axons to be myelinated. However, a needle too small may be clogged with the dissociated OPCs clumped in the needle. We use a pulled glass needle with an outer diameter of 80–110 μm at the tip.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/978-1-60327-931-4_Chapter_12.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ChapterBackmatter>
            <Acknowledgments>
              <Heading>Acknowledgments</Heading>
              <SimplePara>The work cited from our laboratory is currently supported by NMSS grant TR3761 and NIH NS055816. We acknowledge with gratitude the support of the Elisabeth Elser Doolittle Charitable Trust and the Oscar Rennebohm Foundation. We are grateful for past efforts of many previous colleagues.</SimplePara>
            </Acknowledgments>
            <Bibliography ID="Bib1_12">
              <Heading>References</Heading>
              <Citation ID="CR1_12">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Hodes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VM</Initials>
                    <FamilyName>Pratt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Dlouhy</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Genetics of Pelizaeus–Merzbacher disease</ArticleTitle>
                  <JournalTitle>Dev Neurosci</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>383</FirstPage>
                  <LastPage>94</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7530633</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1159/000111361</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXitVKgsb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hodes ME, Pratt VM, Dlouhy SR. Genetics of Pelizaeus–Merzbacher disease. Dev Neurosci 1993;15(6):383–94.</BibUnstructured>
              </Citation>
              <Citation ID="CR2_12">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Mimault</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Giraud</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Courtois</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus–Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease</ArticleTitle>
                  <JournalTitle>Am J Hum Genet</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>360</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10417279</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1086/302483</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXlsFSgsr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mimault C, Giraud G, Courtois V, et al. Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus–Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease. Am J Hum Genet 1999;65(2):360–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR3_12">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Cailloux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Gauthier-Barichard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Mimault</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Genotype–phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelina-ting Disease</ArticleTitle>
                  <JournalTitle>Eur J Hum Genet</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <IssueID>11</IssueID>
                  <FirstPage>837</FirstPage>
                  <LastPage>45</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11093273</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.ejhg.5200537</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhtFylsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cailloux F, Gauthier-Barichard F, Mimault C, et al. Genotype–phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelina-ting Disease. Eur J Hum Genet 2000;8(11):837–45.</BibUnstructured>
              </Citation>
              <Citation ID="CR4_12">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EA</Initials>
                    <FamilyName>Sistermans</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RF</Initials>
                    <FamilyName>de Coo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IJ</Initials>
                    <FamilyName>De Wijs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Van Oost</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Duplication of the proteolipid protein gene is the major cause of Pelizaeus–Merzbacher disease</ArticleTitle>
                  <JournalTitle>Neurology</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>1749</FirstPage>
                  <LastPage>54</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9633722</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1212/WNL.50.6.1749</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1c3psFCkuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sistermans EA, de Coo RF, De Wijs IJ, Van Oost BA. Duplication of the proteolipid protein gene is the major cause of Pelizaeus–Merzbacher disease. Neurology 1998;50(6):1749–54.</BibUnstructured>
              </Citation>
              <Citation ID="CR5_12">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Ellis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Malcolm</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher disease</ArticleTitle>
                  <JournalTitle>Nat Genet</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>333</FirstPage>
                  <LastPage>4</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7519941</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/ng0494-333</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2czjt1WgtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ellis D, Malcolm S. Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher disease. Nat Genet 1994;6(4):333–4.</BibUnstructured>
              </Citation>
              <Citation ID="CR6_12">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Wenger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Rafi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Luzi</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications</ArticleTitle>
                  <JournalTitle>Hum Mutat</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>268</FirstPage>
                  <LastPage>79</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9338580</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1098-1004(1997)10:4&lt;268::AID-HUMU2&gt;3.0.CO;2-D</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXmslOqtLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wenger DA, Rafi MA, Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum Mutat 1997;10(4):268–79.</BibUnstructured>
              </Citation>
              <Citation ID="CR7_12">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Aubourg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Blanche</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Jambaque</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation</ArticleTitle>
                  <JournalTitle>N Engl J Med</JournalTitle>
                  <VolumeID>322</VolumeID>
                  <IssueID>26</IssueID>
                  <FirstPage>1860</FirstPage>
                  <LastPage>6</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2348839</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJM199006283222607</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3c3ntF2nuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Aubourg P, Blanche S, Jambaque I, et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 1990;322(26):1860–6.</BibUnstructured>
              </Citation>
              <Citation ID="CR8_12">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Escolar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Poe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Provenzale</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Transplantation of umbilical-cord blood in babies with infantile Krabbes disease</ArticleTitle>
                  <JournalTitle>N Engl J Med</JournalTitle>
                  <VolumeID>352</VolumeID>
                  <IssueID>20</IssueID>
                  <FirstPage>2069</FirstPage>
                  <LastPage>81</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15901860</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJMoa042604</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXkt1Kltrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbes disease. N Engl J Med 2005;352(20):2069–81.</BibUnstructured>
              </Citation>
              <Citation ID="CR9_12">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Lawler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Watkins</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">A mouse model for X-linked adrenoleukodystrophy</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>94</VolumeID>
                  <IssueID>17</IssueID>
                  <FirstPage>9366</FirstPage>
                  <LastPage>71</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9256488</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.94.17.9366</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXls1Kltr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lu JF, Lawler AM, Watkins PA, et al. A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 1997;94(17):9366–71.</BibUnstructured>
              </Citation>
              <Citation ID="CR10_12">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Forss-Petter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Werner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Berger</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>829</FirstPage>
                  <LastPage>43</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9418970</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1097-4547(19971201)50:5&lt;829::AID-JNR19&gt;3.0.CO;2-W</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnvVGgu7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Forss-Petter S, Werner H, Berger J, et al. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 1997;50(5):829–43.</BibUnstructured>
              </Citation>
              <Citation ID="CR11_12">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Pujol</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Hindelang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Callizot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Bartsch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Schachner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Mandel</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy</ArticleTitle>
                  <JournalTitle>Hum Mol Genet</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>499</FirstPage>
                  <LastPage>505</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11875044</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/hmg/11.5.499</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitlWisbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 2002;11(5):499–505.</BibUnstructured>
              </Citation>
              <Citation ID="CR12_12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Hess</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Saftig</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Hartmann</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>93</VolumeID>
                  <IssueID>25</IssueID>
                  <FirstPage>14821</FirstPage>
                  <LastPage>6</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8962139</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.93.25.14821</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XnsVOmsL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hess B, Saftig P, Hartmann D, et al. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci USA 1996;93(25):14821–6.</BibUnstructured>
              </Citation>
              <Citation ID="CR13_12">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Biffi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Capotondo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Fasano</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>116</VolumeID>
                  <IssueID>11</IssueID>
                  <FirstPage>3070</FirstPage>
                  <LastPage>82</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17080200</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1172/JCI28873</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28XhtFyrsb7I</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Biffi A, Capotondo A, Fasano S, et al Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. J Clin Invest 2006;116(11):3070–82.</BibUnstructured>
              </Citation>
              <Citation ID="CR14_12">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ID</Initials>
                    <FamilyName>Duncan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Hammang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KF</Initials>
                    <FamilyName>Jackson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Wood</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RP</Initials>
                    <FamilyName>Bunge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Langford</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Transplantation of oligodendrocytes and Schwann cells into the spinal cord of the myelin-deficient rat</ArticleTitle>
                  <JournalTitle>J Neurocytol</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>351</FirstPage>
                  <LastPage>60</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3171610</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF01187857</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL1M%2FhtVyntA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Duncan ID, Hammang JP, Jackson KF, Wood PM, Bunge RP, Langford L. Transplantation of oligodendrocytes and Schwann cells into the spinal cord of the myelin-deficient rat. J Neurocytol 1988;17(3):351–60.</BibUnstructured>
              </Citation>
              <Citation ID="CR15_12">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Tontsch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DR</Initials>
                    <FamilyName>Archer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dubois-Dalcq</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ID</Initials>
                    <FamilyName>Duncan</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Transplantation of an oligodendrocyte cell line leading to extensive myelination</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>91</VolumeID>
                  <IssueID>24</IssueID>
                  <FirstPage>11616</FirstPage>
                  <LastPage>20</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7972113</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.91.24.11616</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXitlyrt7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tontsch U, Archer DR, Dubois-Dalcq M, Duncan ID. Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc Natl Acad Sci USA 1994;91(24):11616–20.</BibUnstructured>
              </Citation>
              <Citation ID="CR16_12">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Brustle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KN</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Learish</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Embryonic stem cell-derived glial precursors: a source of myelinating transplants</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>285</VolumeID>
                  <IssueID>5428</IssueID>
                  <FirstPage>754</FirstPage>
                  <LastPage>6</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10427001</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.285.5428.754</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXltVehur8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brustle O, Jones KN, Learish RD, et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999;285(5428):754–6.</BibUnstructured>
              </Citation>
              <Citation ID="CR17_12">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Rosenbluth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hasegawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Schiff</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Myelin formation in myelin-deficient rat spinal cord following transplantation of normal fetal spinal cord</ArticleTitle>
                  <JournalTitle>Neurosci Lett</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <IssueID>1–2</IssueID>
                  <FirstPage>35</FirstPage>
                  <LastPage>40</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2919007</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0304-3940(89)90135-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXhtlejur4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rosenbluth J, Hasegawa M, Schiff R. Myelin formation in myelin-deficient rat spinal cord following transplantation of normal fetal spinal cord. Neurosci Lett 1989;97(1–2):35–40.</BibUnstructured>
              </Citation>
              <Citation ID="CR18_12">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DR</Initials>
                    <FamilyName>Archer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Cuddon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lipsitz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ID</Initials>
                    <FamilyName>Duncan</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>54</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8986741</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nm0197-54</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXitFOgtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Archer DR, Cuddon PA, Lipsitz D, Duncan ID. Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease. Nat Med 1997;3(1):54–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR19_12">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>IR</Initials>
                    <FamilyName>Griffiths</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ID</Initials>
                    <FamilyName>Duncan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>McCulloch</FamilyName>
                  </BibAuthorName>
                  <Year>1981</Year>
                  <ArticleTitle Language="En">Shaking pups: a disorder of central myelination in the spaniel dog. II. Ultrastructural observations on the white matter of the cervical spinal cord</ArticleTitle>
                  <JournalTitle>J Neurocytol</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>847</FirstPage>
                  <LastPage>58</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7310479</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF01262657</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL38%2Fnslahtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Griffiths IR, Duncan ID, McCulloch M. Shaking pups: a disorder of central myelination in the spaniel dog. II. Ultrastructural observations on the white matter of the cervical spinal cord. J Neurocytol 1981;10(5):847–58.</BibUnstructured>
              </Citation>
              <Citation ID="CR20_12">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Gumpel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Baumann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Raoul</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Jacque</FamilyName>
                  </BibAuthorName>
                  <Year>1983</Year>
                  <ArticleTitle Language="En">Survival and differentiation of oligodendrocytes from neural tissue transplanted into new-born mouse brain</ArticleTitle>
                  <JournalTitle>Neurosci Lett</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>307</FirstPage>
                  <LastPage>11</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6193461</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0304-3940(83)90449-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL3s3pvVejtA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gumpel M, Baumann N, Raoul M, Jacque C. Survival and differentiation of oligodendrocytes from neural tissue transplanted into new-born mouse brain. Neurosci Lett 1983;37(3):307–11.</BibUnstructured>
              </Citation>
              <Citation ID="CR21_12">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Baron-Van Evercooren</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Avellana-Adalid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ben Younes-Chennoufi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Gansmuller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Nait-Oumesmar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Vignais</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Cell–cell interactions during the migration of myelin-forming cells transplanted in the demyelinated spinal cord</ArticleTitle>
                  <JournalTitle>Glia</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>147</FirstPage>
                  <LastPage>64</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8929902</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1098-1136(199602)16:2&lt;147::AID-GLIA7&gt;3.0.CO;2-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2s%2Fotlehug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baron-Van Evercooren A, Avellana-Adalid V, Ben Younes-Chennoufi A, Gansmuller A, Nait-Oumesmar B, Vignais L. Cell–cell interactions during the migration of myelin-forming cells transplanted in the demyelinated spinal cord. Glia 1996;16(2):147–64.</BibUnstructured>
              </Citation>
              <Citation ID="CR22_12">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MS</Initials>
                    <FamilyName>Windrem</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Nunes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WK</Initials>
                    <FamilyName>Rashbaum</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>93</FirstPage>
                  <LastPage>7</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14702638</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nm974</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlsFGh</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Windrem MS, Nunes MC, Rashbaum WK, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004;10(1):93–7.</BibUnstructured>
              </Citation>
              <Citation ID="CR23_12">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kondo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Wenger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Gallo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ID</Initials>
                    <FamilyName>Duncan</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>102</VolumeID>
                  <IssueID>51</IssueID>
                  <FirstPage>18670</FirstPage>
                  <LastPage>5</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16352725</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.0506473102</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28Xpt12r</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kondo Y, Wenger DA, Gallo V, Duncan ID. Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice. Proc Natl Acad Sci USA 2005;102(51):18670–5.</BibUnstructured>
              </Citation>
              <Citation ID="CR24_12">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Yuan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Chittajallu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Belachew</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>McBain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Gallo</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>70</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>529</FirstPage>
                  <LastPage>45</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12404507</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.10368</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xos1Ckurw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yuan X, Chittajallu R, Belachew S, Anderson S, McBain CJ, Gallo V. Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies. J Neurosci Res 2002;70(4):529–45.</BibUnstructured>
              </Citation>
              <Citation ID="CR25_12">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Avellana-Adalid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Nait-Oumesmar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Lachapelle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Baron-Van Evercooren</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Expansion of rat oligodendrocyte progenitors into proliferative “oligospheres” that retain differentiation potential</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>558</FirstPage>
                  <LastPage>70</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8875321</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1097-4547(19960901)45:5&lt;558::AID-JNR6&gt;3.0.CO;2-B</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XlsVOlurs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Avellana-Adalid V, Nait-Oumesmar B, Lachapelle F, Baron-Van Evercooren A. Expansion of rat oligodendrocyte progenitors into proliferative “oligospheres” that retain differentiation potential. J Neurosci Res 1996;45(5):558–70.</BibUnstructured>
              </Citation>
              <Citation ID="CR26_12">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lundberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lipsitz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LT</Initials>
                    <FamilyName>OConnor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ID</Initials>
                    <FamilyName>Duncan</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Generation of oligodendroglial progenitors from neural stem cells</ArticleTitle>
                  <JournalTitle>J Neurocytol</JournalTitle>
                  <VolumeID>27</VolumeID>
                  <IssueID>7</IssueID>
                  <FirstPage>475</FirstPage>
                  <LastPage>89</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11246488</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1006953023845</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M3gtFKnuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhang SC, Lundberg C, Lipsitz D, OConnor LT, Duncan ID. Generation of oligodendroglial progenitors from neural stem cells. J Neurocytol 1998;27(7):475–89.</BibUnstructured>
              </Citation>
              <Citation ID="CR27_12">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lipsitz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ID</Initials>
                    <FamilyName>Duncan</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Self-renewing canine oligodendroglial progenitor expanded as oligospheres</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>181</FirstPage>
                  <LastPage>90</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9788277</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1097-4547(19981015)54:2&lt;181::AID-JNR6&gt;3.0.CO;2-A</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmsFCnsbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhang SC, Lipsitz D, Duncan ID. Self-renewing canine oligodendroglial progenitor expanded as oligospheres. J Neurosci Res 1998;54(2):181–90.</BibUnstructured>
              </Citation>
              <Citation ID="CR28_12">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Learish</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Brustle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ID</Initials>
                    <FamilyName>Duncan</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin</ArticleTitle>
                  <JournalTitle>Ann Neurol</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>716</FirstPage>
                  <LastPage>22</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10553988</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/1531-8249(199911)46:5&lt;716::AID-ANA6&gt;3.0.CO;2-M</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3c%2FhvFCitA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Learish RD, Brustle O, Zhang SC, Duncan ID. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin. Ann Neurol 1999;46(5):716–22.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ChapterBackmatter>
        </Chapter>
      </Part>
    </Book>
  </Series>
</Publisher>